Search
Descriptor English: Dopamine Antagonists
Descriptor Spanish: Antagonistas de Dopamina
Descriptor Portuguese: Antagonistas de Dopamina
Descriptor French: Antagonistes de la dopamine
Entry term(s): Antagonist, Dopamine
Antagonist, Dopamine Receptor
Antagonist, Dopaminergic
Antagonists, Dopamine
Antagonists, Dopamine Receptor
Antagonists, Dopaminergic
Blocker, Dopamine
Blockers, Dopamine
Dopamine Antagonist
Dopamine Blocker
Dopamine Blockers
Dopamine Receptor Antagonist
Dopamine Receptor Antagonists
Dopaminergic Antagonist
Dopaminergic Antagonists
Receptor Antagonist, Dopamine
Receptor Antagonists, Dopamine
Tree number(s): D27.505.519.625.150.175
D27.505.696.577.150.175
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D018492
Scope note: Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Previous Indexing: Dopamine/antagonists & inhibitors (1966-1994)
Public MeSH Note: 95
History Note: 95
Entry Version: DOPAMINE ANTAG
DeCS ID: 32275
Unique ID: D018492
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1995/01/01
Date of Entry: 1994/06/01
Revision Date: 2020/05/27
Dopamine Antagonists - Preferred
Concept UI M0027734
Scope note Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME.
Preferred term Dopamine Antagonists
Entry term(s) Antagonist, Dopamine
Antagonist, Dopamine Receptor
Antagonist, Dopaminergic
Antagonists, Dopamine
Antagonists, Dopamine Receptor
Antagonists, Dopaminergic
Blocker, Dopamine
Blockers, Dopamine
Dopamine Antagonist
Dopamine Blocker
Dopamine Blockers
Dopamine Receptor Antagonist
Dopamine Receptor Antagonists
Dopaminergic Antagonist
Dopaminergic Antagonists
Receptor Antagonist, Dopamine
Receptor Antagonists, Dopamine



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey